Cui JW - Search Results

1

Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial.

Liu Y, Zhu XZ, Xiao Y, Wu SY, Zuo WJ, Yu Q, Cao AY, Li JJ, Yu KD, Liu GY, Wu J, Sun T, Cui JW, Lv Z, Li HP, Zhu XY, Jiang YZ, Wang ZH, Shao ZM. Liu Y, et al. Among authors: cui jw. Cell Res. 2023 May;33(5):389-402. doi: 10.1038/s41422-023-00795-2. Epub 2023 Mar 27. Cell Res. 2023. PMID: 36973538 Free PMC article. Clinical Trial.

2

Prognostic value of MICA/B in cancers: a systematic review and meta-analysis.

Zhao Y, Chen N, Yu Y, Zhou L, Niu C, Liu Y, Tian H, Lv Z, Han F, Cui J. Zhao Y, et al. Oncotarget. 2017 Oct 3;8(56):96384-96395. doi: 10.18632/oncotarget.21466. eCollection 2017 Nov 10. Oncotarget. 2017. PMID: 29221214 Free PMC article.

3

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.

Chen N, Zhao G, Yan X, Lv Z, Yin H, Zhang S, Song W, Li X, Li L, Du Z, Jia L, Zhou L, Li W, Hoffman AR, Hu JF, Cui J. Chen N, et al. Genome Biol. 2018 Dec 11;19(1):218. doi: 10.1186/s13059-018-1594-y. Genome Biol. 2018. PMID: 30537986 Free PMC article.

4

Precision Detection Technology: Equipping Precision Oncology with Wings.

Bai R, Lv Z, Chen X, Guo H, Bai L, Tian H, Li W, Cui J. Bai R, et al. J Oncol. 2020 Jul 9;2020:9068121. doi: 10.1155/2020/9068121. eCollection 2020. J Oncol. 2020. PMID: 32695166 Free PMC article. Review.

5

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?

Bai R, Chen N, Liang T, Li L, Lv Z, Lv X, Cui J. Bai R, et al. Front Oncol. 2020 Jul 21;10:912. doi: 10.3389/fonc.2020.00912. eCollection 2020. Front Oncol. 2020. PMID: 32793461 Free PMC article. Review.

6

Mechanisms of Cancer Resistance to Immunotherapy.

Bai R, Chen N, Li L, Du N, Bai L, Lv Z, Tian H, Cui J. Bai R, et al. Front Oncol. 2020 Aug 6;10:1290. doi: 10.3389/fonc.2020.01290. eCollection 2020. Front Oncol. 2020. PMID: 32850400 Free PMC article. Review.

7

Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors.

Bai R, Lv Z, Xu D, Cui J. Bai R, et al. Biomark Res. 2020 Aug 26;8:34. doi: 10.1186/s40364-020-00209-0. eCollection 2020. Biomark Res. 2020. PMID: 32864131 Free PMC article. Review.

8

Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis.

Chen F, Chen N, Lv Z, Li L, Cui J. Chen F, et al. J Cancer. 2021 Jan 18;12(6):1687-1697. doi: 10.7150/jca.51845. eCollection 2021. J Cancer. 2021. PMID: 33613756 Free PMC article.

9

Single Nucleotide Polymorphisms in HOTAIR Are Related to Breast Cancer Risk and Prognosis in the Northeastern Chinese Population.

Lv Z, Kou C, Chen N, Jia L, Sun X, Gao Y, Bai R, Yang M, Cui J. Lv Z, et al. Front Oncol. 2021 Jul 12;11:706428. doi: 10.3389/fonc.2021.706428. eCollection 2021. Front Oncol. 2021. PMID: 34322392 Free PMC article.

10

Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors.

Bai R, Li L, Chen X, Chen N, Song W, Zhang Y, Lv Z, Han F, Zhao Y, Li W, Cui J. Bai R, et al. J Oncol. 2021 May 10;2021:9935076. doi: 10.1155/2021/9935076. eCollection 2021. J Oncol. 2021. PMID: 34335763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters